The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
Sue Dumbauld got an alert from her Apple Watch that her heart rate was dangerously high. This inspired her to exercise ahead ...
If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...
Medpage Today on MSN6d
SGLT2 Inhibitors May Slow Nonsevere Aortic Stenosis ProgressionFor the first time, researchers said SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis ...
News Medical on MSN1d
New drug ataciguat shows promise for managing aortic valve stenosisAortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.
WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback